CIK 0000896264 · Medicinal Chemicals & Botanical Products (SIC 2833) · NYSE · incorporated in UT · fiscal year ends 01/03
| FY2025 | FY2023 | FY2022 | FY2020 | |
|---|---|---|---|---|
| Revenue (USD) | 925.3 M | 998.6 M | ||
| Net income (USD) | 124.7 M | 126.2 M | ||
| Diluted EPS (USD/shares) | 0.58 | 3.59 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-10-05 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 10-Q | 10-Q | 2026-07-04 |
| 2026-08-04 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-04 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-25 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-25 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-07-27 | 4 | FORM 4 | 2026-07-23 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-16 |
| 2026-06-16 | 144 | 144 | |
| 2026-06-16 | 4 | FORM 4 | 2026-06-12 |
| 2026-06-15 | 144 | 144 | |
| 2026-06-15 | 11-K | 11-K | 2025-12-31 |
| 2026-06-08 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-08 | 144 | 144 | |
| 2026-06-01 | 4 | FORM 4 | 2026-06-01 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-28 |
| 2026-05-28 | 144 | 144 | |
| 2026-05-28 | 4 | FORM 4 | 2026-05-27 |
| 2026-05-27 | 144 | 144 |
Forms on file (last 1,000): 4 731, 8-K 71, 144 53, 10-Q 27, SC 13G/A 18, DEFA14A 11, 4/A 10, SC 13D/A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=USNA (0.002 USD), /gw/filings/filings?ticker=USNA&form=8-K, /gw/filings/facts?ticker=USNA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange